… Here, we report the primary efficacy and safety results from the phase 3 … safety/tolerability
profile of vedolizumab in this study was comparable with GEMINI 1 and the integrated safety …

… We investigated the efficacy and safety of vedolizumab in … analyses of the safety and efficacy
of vedolizumab in patients … years, we provide safety and efficacy data for GEMINI patients …

… Vedolizumab is indicated in the treatment of moderate to severe active Crohn's disease and
ulcerative colitis … outcomes of vedolizumab in the treatment of patients with ulcerative colitis. …

… Vedolizumab is a humanized monoclonal IgG1 antibody … tract, so use of vedolizumab could
provide advantages compared … was to examine the efficacy and safety of vedolizumab for the …

… to evaluate the efficacy and safety of vedolizumab in the … Monitoring the efficacy and safety
of vedolizumab is essential … to assess the efficacy and safety of vedolizumab induction and …

… and safety of vedolizumab in an inflammatory bowel disease (IBD) clinical practice. … safety
of vedolizumab in an IBD referral practice and to assess the overall durability of vedolizumab …

… the safety of long-term vedolizumab treatment. Patient-reported health-related quality of life
[HRQL] assessments and efficacy … This report presents interim efficacy and safety data for …

… Here, we report the effectiveness and safety of vedolizumab induction therapy in patients
with … This article presents the week 14 efficacy and safety results of this study. Vedolizumab …

… treatment of ulcerative colitis (UC) and Crohn's disease (CD). We report an integrated summary
of the safety of vedolizumab. Design Safety data (May 2009–June 2013) from six trials of …

Background: Data on vedolizumab (VDZ) use in inflammatory bowel disease (IBD) patients
are still limited. We aimed to assess the effectiveness and tolerability of VDZ in a real-life …